news New painless vaccine technology targets viruses 13 January 2025 | By Drug Target Review Learn how Kindeva and Emervax are advancing vaccine delivery with painless, needle-free technology designed to improve accessibility and uptake worldwide.
news Radiotracer targets key cancer biomarker for precision treatment 23 December 2024 | By Drug Target Review A breakthrough in molecular imaging could transform how doctors target solid tumours, offering more personalised and effective treatment options.
news Pathogens exert physical force to avoid ingestion within phagocytes 7 December 2023 | By Drug Target Review A previously unknown process by which pathogens breach immune defences offers promise for treating infectious diseases.
news Specialised white blood cells could lead to more preventative treatments 18 July 2023 | By Izzy Wood (Drug Target Review) Australian researchers analyse the way specialised white blood cells produce an immune response, which could lead to the development of preventative treatments for cancer and infectious diseases.
news The immune system’s power over antibiotics for infections 28 March 2023 | By Taylor Mixides (Drug Target Review) The natural process of removing damaged cell parts could present an alternative to antibiotics, especially where bacteria have become resistant to existing drugs.
news Research highlights interaction of mycobacteria with red blood cells and its role in lung disease 1 April 2022 | By Ria Kakkad (Drug Target Review) A new study has found that mycobacteria are associated with red blood cells at lung infection sites, an interaction that has escaped scientists for 140 years.
news Possible connection between HIV and tuberculosis revealed 17 February 2022 | By Ria Kakkad (Drug Target Review) A recent study has shown that antiretroviral therapy timing impacts the animal version of HIV and latent tuberculosis.
news Scientists develop novel strategy for tuberculosis vaccine 25 August 2021 | By Anna Begley (Drug Target Review) A research team have created a new strategy for developing an effective vaccine against a widespread form of tuberculosis.
news New method for rapid development of vaccines for pre-clinical tests 19 January 2021 | By Victoria Rees (Drug Target Review) Using synthetic chemistry, researchers have fused hydrophobic adjuvants with water-soluble proteins to create a new type of vaccine.
article The latest pre-clinical HIV vaccine developments 25 November 2020 | By Victoria Rees (Drug Target Review) This article lists three of the most recent advances in pre-clinical HIV research and vaccine development.
news Two compounds exhibit antibacterial properties against tuberculosis 31 July 2020 | By Victoria Rees (Drug Target Review) Tested on two assays, researchers have shown that Redx03863 and Redx04739 can combat tuberculosis and do not lead to resistance.
news Imaging and machine learning system created to discover tuberculosis drugs 24 July 2020 | By Victoria Rees (Drug Target Review) Researchers have developed MorphEUS, a technology to identify new drugs that combat M. tuberculosis by revealing how compounds destroy the bacteria.
news £280 million donated for COVID-19 research in three months 21 April 2020 | By Victoria Rees (Drug Target Review) A study has shown that the COVID-19 pandemic has resulted in a high level of research donations, making the condition the third most funded disease on average by year.
news Novel technique reveals how TB antibiotics reach their targets 28 June 2019 | By Drug Target Review Researchers have used a new method to understand how antibiotics fight TB, which can guide future drug developments.
news Boosting immune cells could provide TB treatment 28 June 2019 | By Drug Target Review A new study has identified a class of immune cells that respond to tuberculosis, indicating a drug target for the condition.
